CSIMarket
 


Optinose Inc   (OPTN)
Other Ticker:  
 
 

OPTN's Revenue Growth by Quarter and Year

Optinose Inc 's Revenue results by quarter and year




OPTN Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 19.86 20.86 22.51
III Quarter September - 19.82 20.08 21.83
II Quarter June - 19.45 20.58 18.36
I Quarter March 14.88 11.85 14.76 11.96
FY   14.88 70.98 76.28 74.66



OPTN Revenue first quarter 2024 Y/Y Growth Comment
Optinose Inc achieved in the first quarter 2024, above Company average Revenue growth of 25.57% year on year, to $ 14.88 millions.

Looking into first quarter 2024 results within Major Pharmaceutical Preparations industry 81 other companies have achieved higher Revenue growth. While Optinose Inc ' s Revenue rise of 25.57% ranks overall at the positon no. 1521 in the first quarter 2024.




OPTN Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - -4.79 % -7.33 % 37.68 %
III Quarter September - -1.29 % -8.02 % 41.39 %
II Quarter June - -5.49 % 12.09 % 78.77 %
I Quarter March 25.57 % -19.72 % 23.41 % 69.41 %
FY   - -6.95 % 2.17 % 52 %

Financial Statements
Optinose Inc 's first quarter 2024 Revenue $ 14.88 millions OPTN's Income Statement
Optinose Inc 's first quarter 2023 Revenue $ 11.85 millions Quarterly OPTN's Income Statement
New: More OPTN's historic Revenue Growth >>


OPTN Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - 0.2 % 3.88 % 3.11 %
III Quarter September - 1.9 % -2.43 % 18.9 %
II Quarter June - 64.14 % 39.43 % 53.51 %
I Quarter March -25.08 % -43.19 % -34.43 % -26.85 %
FY (Year on Year)   - -6.95 % 2.17 % 52 %




Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #82
Healthcare Sector #225
Overall #1521

Revenue Y/Y Growth Statistics
High Average Low
56.19 % 21.9 % -9.34 %
(Sep 30 2021)   (Jun 30 2023)
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #82
Healthcare Sector #225
Overall #1521
Revenue Y/Y Growth Statistics
High Average Low
56.19 % 21.9 % -9.34 %
(Sep 30 2021)   (Jun 30 2023)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Optinose Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
85.67 % 12.14 % -43.2 %
(Sep 30 2019)  


OPTN's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Optinose Inc reported fall in Revenue sequentially by -25.08% to $ 14.88 millions, from $ 19.86 millions released in the previous reporting period.

If you evaluate present downturn in the quarter, you must take into consideration, that frequently I. Quarter 2024 results appear to be sluggish relative to the preciding period

Within Major Pharmaceutical Preparations industry 86 other companies have achieved higher Revenue quarter on quarter growth. While Optinose Inc 's Revenue growth quarter on quarter, overall rank is 1987.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #87
Healthcare Sector #250
Overall #1987
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #87
Healthcare Sector #250
Overall #1987
Revenue Q/Q Growth Statistics
High Average Low
85.67 % 12.14 % -43.2 %
(Sep 30 2019)  


OPTN's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Optinose Inc reported fall in Revenue from the fourth quarter by -25.08% to $ 14.88 millions, from $ 19.86 millions declared in the previous reporting period.

It's not important concern, as I. Quarter Revenue frequently seem to dip in the I. Quarter.

Within Major Pharmaceutical Preparations industry 86 other companies have achieved higher Revenue quarter on quarter growth. While Optinose Inc 's Revenue growth quarter on quarter, overall rank is 1987.


Optinose Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 74.02 $ 70.99 $ 71.98 $ 72.23 $ 73.36
Y / Y Revenue Growth (TTM) 0.9 % -6.93 % -7.64 % -9.34 % -5.28 %
Year on Year Revenue Growth Overall Ranking # 1591 # 1158 # 809 # 716 # 555
Seqeuential Revenue Change (TTM) 4.27 % -1.38 % -0.35 % -1.54 % -3.82 %
Seq. Revenue Growth (TTM) Overall Ranking # 1521 # 1390 # 1776 # 2094 # 2282




Cumulative Revenue growth Comment
Although Optinose Inc 's Annual Revenue growth year on year were below company's average 21.9% , Revenue announced in the Mar 31 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 0.9% year on year, from -6.93% in Dec 31 2023.

In the Healthcare sector 232 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1158 to 1591.

Revenue TTM Q/Q Growth Statistics
High Average Low
56.19 %
21.9 %
-9.34 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 82
Healthcare Sector # 233
Overall # 1591

Revenue TTM Y/Y Growth Statistics
High Average Low
56.19 %
21.9 %
-9.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 82
Sector # 225
S&P 500 # 1521
Cumulative Revenue growth Comment
Although Optinose Inc 's Annual Revenue growth year on year were below company's average 21.9% , Revenue announced in the Mar 31 2024 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 0.9% year on year, from -6.93% in Dec 31 2023.

In the Healthcare sector 232 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1158 to 1591.

Revenue TTM Q/Q Growth Statistics
High Average Low
56.19 %
21.9 %
-9.34 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 82
Healthcare Sector # 233
Overall # 1591

Revenue TTM Y/Y Growth Statistics
High Average Low
56.19 %
21.9 %
-9.34 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 82
Sector # 225
S&P 500 # 1521




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OPTN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for OPTN's Competitors
Revenue Growth for Optinose Inc 's Suppliers
Revenue Growth for OPTN's Customers

You may also want to know
OPTN's Annual Growth Rates OPTN's Profitability Ratios OPTN's Asset Turnover Ratio OPTN's Dividend Growth
OPTN's Roe OPTN's Valuation Ratios OPTN's Financial Strength Ratios OPTN's Dividend Payout Ratio
OPTN's Roa OPTN's Inventory Turnover Ratio OPTN's Growth Rates OPTN's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2024
Enzon Pharmaceuticals inc 44.74%$ 44.743 millions
Genedx Holdings Corp 44.67%$ 44.674 millions
Astrotech Corp42.86%$ 42.857 millions
Adma Biologics Inc 42.51%$ 42.511 millions
Evolus Inc 42.21%$ 42.214 millions
Agilon Health Inc 41.21%$ 41.210 millions
Clearpoint Neuro Inc 40.60%$ 40.604 millions
Orthopediatrics Corp39.84%$ 39.844 millions
Theravance Biopharma inc 39.22%$ 39.224 millions
Corcept Therapeutics Inc38.95%$ 38.952 millions
Zai Lab Limited38.78%$ 38.779 millions
Tela Bio Inc 38.28%$ 38.277 millions
Shockwave Medical Inc 35.72%$ 35.720 millions
Biocryst Pharmaceuticals Inc 34.87%$ 34.870 millions
Deciphera Pharmaceuticals Inc 34.55%$ 34.546 millions
United Therapeutics Corporation33.70%$ 33.695 millions
Cyclo Therapeutics Inc 32.83%$ 32.832 millions
Maxcyte inc 32.25%$ 32.248 millions
Eton Pharmaceuticals Inc 32.11%$ 32.108 millions
Agile Therapeutics Inc32.07%$ 32.074 millions
Guardant Health Inc 30.90%$ 30.903 millions
Harmony Biosciences Holdings inc 29.38%$ 29.385 millions
Axonics Inc 29.16%$ 29.162 millions
Ani Pharmaceuticals Inc28.70%$ 28.697 millions
P3 Health Partners Inc 28.61%$ 28.606 millions
Exagen Inc 28.36%$ 28.362 millions
Viemed Healthcare Inc 27.90%$ 27.902 millions
Inspire Medical Systems inc 27.64%$ 27.644 millions
Amicus Therapeutics inc 27.32%$ 27.317 millions
Cvrx inc 27.27%$ 27.272 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com